

share
Letrozole CAS NO 1128090-51-5
Unit Price:
CAS No.:1128090-51-5
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Letrozole is a potent, selective, and non-steroidal aromatase inhibitor of the third generation. This compound is critical for the targeted inhibition of estrogen biosynthesis, offering a high degree of specificity. It is an essential active pharmaceutical ingredient (API) and a key reference standard for research and development. Primary industrial users include pharmaceutical manufacturers, contract research organizations (CROs), and analytical laboratories focused on oncology and endocrinology.
Application
- Pharmaceutical API: Manufacture of finished dosage forms for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
- Reference Standard: Used in quality control laboratories for the identification and assay of Letrozole in raw materials and finished products via HPLC, GC, or spectroscopic methods.
- Research & Development: Serves as a critical biochemical tool in preclinical studies investigating aromatase inhibition, estrogen-dependent pathways, and cancer biology.
- Analytical Testing: Employed as a certified standard for method development, validation, and regulatory compliance testing (e.g., USP, EP monographs).
- Formulation Development: Used in the development of novel drug delivery systems, including tablets and other solid oral dosage forms.
Basic Information
| Product Name | Letrozole |
| CAS No. | 112809-51-5 |
| Molecular Formula | C17H11N5 |
| Molecular Weight | 285.31 g/mol |
| Synonyms | 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile; CGS 20267; Femara®; LTZ; NSC 719345 |
| EINECS | Contact for details |
Quality Control
Our Letrozole is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets stringent specifications for identity, purity, and potency, aligning with major pharmacopeial standards (USP/EP). A detailed Certificate of Analysis (COA) is provided with every shipment, confirming compliance with your specified requirements.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The product is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to reference spectrum |
| Identification (HPLC) | Retention time matches reference standard |
| Assay (HPLC) | 98.0% - 102.0% (on anhydrous basis) |
| Water Content (KF) | ≤ 0.5% |
| Related Substances (HPLC) | Total impurities ≤ 1.0% Any single impurity ≤ 0.5% |
| Residual Solvents (GC) | Complies with ICH Q3C guidelines |
| Heavy Metals | ≤ 20 ppm |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Enzalutamide CAS NO 915087-33-1


Nafoxidine CAS NO 1845-11-0


Nafoxidine CAS NO 1847-63-8


Aminoglutethimide Phosphate CAS NO 13256-45-6


Flutamide CAS NO 13311-84-7


Tamoxifen CAS NO 15917-50-7


Fadrozole Hydrochloride CAS NO 102676-31-3


Fadrozole CAS NO 102676-47-1


Mlv 208 CAS NO 102820-99-5


Exell CAS NO 104559-06-0


Minamestane CAS NO 105051-87-4


Tamoxifen Methiodide CAS NO 107256-99-5


Fd-838 CAS NO 110341-78-1


Declaben CAS NO 111149-90-7


Endoxifen CAS NO 112093-28-4


(D-Tyr5)-Leuprolide CAS NO 112710-57-3


(S)-Bicalutamide CAS NO 113299-38-0


(R)-Bicalutamide CAS NO 113299-40-4


Tat 59 CAS NO 115767-74-3


Idoxifene CAS NO 116057-75-1
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






